METHODS

The Maternal PKU Collaborative Study
The Maternal PKU Collaborative Study, begun in 1984, prospectively evaluates the effects of dietary treatment during pregnancy. 8 The Children's Hospital of Los Angeles serves as the coordinating center for data entry and analysis. Four regional contributing centers in the United States, 2 in Canada, and 1 in Germany are responsible for recruitment and data collection at 78 participating centers. 8 The participating centers obtained institutional review board approval either by submitting a proposal to their research committees or by accepting approval from the contributing center hospital. The institutional review boards from each of the 4 contributing centers reviewed the protocols and procedures and approved separate informed consent forms. Previous articles have focused on nutritional 9 and genetic 10 characteristics of the mother and on offspring anomalies, 11 birth measurements, 12 neonatal neurological status, 13 and preliminary results of developmental testing. 14 All women with PKU known to metabolic clinics in the United States, Canada, and Germany were tracked at the start of the study and enrolled at the time of pregnancy. Women with mild hyperphenylalaninemia (MHP) were also invited to participate. Women with PKU were offered a low-phenylalanine diet prior to or during pregnancy with the aim of maintaining metabolic control (plasma phenylalanine, Յ10 mg/dL [Յ605 µmol/L]). The women with MHP had plasma phenylalanine levels of less than 10 mg/dL (605 µmol/L) on a normal diet and treatment was not recommended. Almost all pregnant women with PKU or MHP agreed to participate. Spouses of men with PKU, women who had a previous child with a metabolic disorder, and women working in the hospitals where the study took place were then recruited to participate in the nonhyperphenylalaninemic (non-HPA) comparison group.
The final study includes 572 pregnancies, of which 412 were completed. There were 75 spontaneous terminations, 79 elective terminations, 3 stillborns, and 3 ectopic pregnancies. There were 4 sets of twins. Eight children died of complications associated with maternal PKU. A standard protocol for treatment of maternal PKU was provided to each participating center. The protocol specified the monitoring of plasma phenylalanine levels and dietary intake on a weekly basis and visits to a metabolic center once per trimester. Indices of nutrition status (including weight gain and amino acid levels) were evaluated during each trimester. Ultrasound examinations were performed at 20, 28, and 34 gestational weeks. In addition, an obstetrician followed up each woman for regular prenatal care. Offspring were evaluated developmentally in the neonatal period and at 12 and 24 months (Bayley Scales of Infant Development). Thereafter, they were evaluated every 2 to 3 years, through age 10 years. Clinic attendance, adherence to medical recommendations, and cooperation with follow-up varied considerably.
Preschool Evaluations. At the time of this report, 368 children from the United States and Canada meeting the criteria for inclusion had reached their 4-year birthday. Two offspring diagnosed as having PKU and 2 offspring diagnosed as having MHP were excluded. The children from Germany were excluded because a different test battery was used. Of the 253 offspring receiving the preschool psychological test battery, 149 were born to mothers with PKU, 33 had mothers with untreated MHP, and 71 had mothers in the non-HPA comparison group.
The Psychological Assessment Battery. The battery of psychological tests administered is presented in 16, 17 By the seventh year of the study, additional tests were administered, but were scheduled at age 4 years. While 253 children received the McCarthy Scales of Children's Abilities, 183 received the full battery of tests. The evaluation obtained closest to age 4 years was used when more than 1 was performed.
The Test of Language DevelopmentPrimary provides a composite spoken language score, which includes scales for listening, speaking, semantics, syntax, and phonology. 18 The Achenbach Child Behavior Checklist includes 112 behavioral items The Home Observation for Measurement of the Environment (HOME) scale provides a measure of the physical circumstances of the home, variety of experiences offered to the child, and the richness of language used. It provides a total environmental stimulation score derived from the sum of items checked. 21 When the evaluation was performed outside of the home, the inventory was administered through an interview format. Scores less than 85% were considered low.
The Wechsler Adult Intelligence Scale-Revised 22 was used as the measure of maternal IQ and was administered to all women who had not been administered this test within 5 years of the start of the study.
Procedures
The majority of evaluations were conducted in the homes of the participants. The psychologists were not informed about maternal metabolic control during pregnancy or maternal IQ results. Standard test administration procedures were followed. Informed consent was obtained at the time of enrollment. All completed test protocols were sent without names to the psychology coordinating center in Boston, Mass, where results were recorded and checked for accuracy. They were then submitted to the coordinating center in Los Angeles, Calif, where the data were entered.
Data Analyses
Timing of maternal metabolic control was defined as the number of weeks of gestation that elapsed before plasma phenylalanine levels remained lower than 10 mg/dL (605 µmol/L). The maternal PKU offspring were categorized into 4 treatment groups related to timing of maternal metabolic control: (1) prior to pregnancy, (2) more than 0 up to 10 weeks; (3) more than 10 up to 20 weeks; and (4) more than 20 weeks or never in control. Results of cognitive and behavioral assessments in HPA and untreated MHP offspring were compared with results in the offspring from women in the non-HPA comparison group. Since timing of maternal metabolic control and other maternal factors were taken into account in multivariate analyses, each offspring was considered a case. Thirty-nine mothers had more than 1 child in the study. The distribution of test scores permitted use of parametric procedures. Statistical power was calculated at more than 80% for comparisons of each subgroup with the non-HPA comparison group if differences of 10 points were found on the standardized psychological tests, but not large enough to detect differences of 5 or fewer points in the untreated MHP and prior to pregnancy groups. Factor analysis was performed to confirm domains of strengths and weaknesses in the children (details available from the authors on request). The relationship between maternal metabolic control and offspring outcome (risk for a low GCI score) was determined through the use of logistic regressions. Variables that were potential confounders of the relationship between in utero exposure to phenylalanine and offspring GCI scores also were entered in the initial model. These included maternal IQ, assigned maternal plasma phenylalanine level (plasma phenylalanine level when on an unrestricted diet), maternal age, socioeconomic status, 23 and level of stimulation provided to the child in the home. The model was reduced, with variables being dropped 1 at a time, until remaining variables reached PϽ. 30 . For treated HPA pregnancies, the effect of birth order was tested through paired t tests. Also, for the treated HPA pregnancies, results from the 2-year evaluation were compared with results from the preschool evaluation at age 4 years using paired t tests. Statistical programs from Systat 24 and Stata 25 were used. PϽ.05 was used as the criterion for significance.
RESULTS
Maternal Characteristics
A total of 205 women enrolled in the Maternal PKU Collaborative Study gave birth to 253 offspring who received evaluations at age 4 years. As noted in TABLE 2, the majority of women with PKU attained metabolic control after 10 gestational weeks. Maternal IQ was lower in these women and their assigned plasma phenylalanine level was higher. Their education and level of social position were lower.
Preschool evaluations were not obtained for 115 children, usually because their mothers could not be located or did not respond to repeated telephone calls and letters. Missing cases were almost evenly distributed among the study groups ( 2 5 = 9.3; P = .10). Using t tests, no significant differences were found between mothers whose children received the preschool evaluation and mothers of children for whom these data were missing in terms of the following variables: maternal IQ (t 303 = 0.91; P = .36), assigned plasma phenylalanine level (t 262 = 0.91; P = .36), or socioeconomic position (P = .80). Children whose mothers were younger (t 370 = 2.4; P = .01) and whose average plasma phenylalanine levels were higher during pregnancy (t 269 = 2.1; P = .04) were less likely to have been evaluated. A group of 10 children had mothers who attained metabolic control after pregnancy began but within 6 weeks of gestation. They had a mean (SD) GCI score of 96 (15) . Overall, they performed not as well as those treated prior to conception (mean [SD] GCI score, 99 [13] ). Two performed more than 1 SD below the normative mean (GCI Յ86). None of these children performed in the range of mental retardation (GCI Յ72), while 8 of 16 offspring whose mothers attained metabolic control between 6 and 10 weeks' gestation had a GCI score of 86 or less, with 3 of them having a score of 72 or less.
In analyses describing the developmental profile in maternal PKU, children from the untreated MHP and treated pregnancies were grouped since they shared patterns of high and low scores. Factor analysis of data from the combined HPA groups confirmed 3 factors: verbal/memory (varimax rotation factor loadings Ͼ0.75), perceptual performance/motor score (factor loadings Ͼ0.67), and quantitative (factor loading, 0.60). In all HPA groups, there was a consistent pattern of weaknesses in language/memory and quantitative domains on the McCarthy Scales. The verbal score was significantly lower than the perceptual performance score (t 181 = −4.9; PϽ.001) and the motor score (t 173 = −3.2; P = .002), but was not significantly different from the quantitative score (t 181 = 0.82; P = .41) or the memory score (t 181 = 0.42; P = .67). The results of the Test of Language Development suggest specific effects in expressive language and memory. Scores were 1 SD or more below the mean for 79% of the children on sentence imitation, 70% on word discrimination, 86% on grammar use, and 53% on articulation. The children perfor- 19 ) of the children received a rating in the clinical range on the total behavior problems index of the Achenbach Child Behavior Checklist. Their parents rated them as more external than internal (t 135 = 7.5; PϽ.001). They were less likely to be rated as withdrawn than as having problems with attention (t 135 = 2.9; P = .005) or social relationships (t 135 = 2.4; P = .02). Few children were rated as having somatic problems, anxiety, or delinquency.
The children appeared to develop appropriate social skills at a slower rate. On the Vineland Adaptive Behavior Scales, parents were somewhat more likely to note slower development in social relationships than in daily living skills (t 143 = 1.6; P = .12).
Maternal Variables and Offspring Outcome in HPA Pregnancies
Maternal IQ was significantly related to the HOME score (r = 0.36; PϽ.001) and to timing of maternal metabolic control (r = 0.58; PϽ.001). TABLE 4 summarizes logistic regression analyses used to determine the relative risk for a GCI score of 86 or less. The variables that best predicted overall risk for a low GCI score in the offspring were low maternal IQ, an assigned plasma phenylalanine level greater than 20 mg/dL (1210 µmol/L), delayed maternal metabolic control during pregnancy, and a low HOME score, reflecting the postnatal environment. The final model had a sensitivity rating of 82% and a specificity rating of 65%, with 74% of cases correctly classified.
Effect of Birth Order
Twenty-seven mothers treated for maternal PKU had more than 1 child enrolled in the study who received a preschool evaluation at age 4 years. On average, the children were 2.6 years apart in age. The mean difference in timing of maternal metabolic control was 2.2 weeks, with subsequent pregnancies being treated later than first pregnancies (t = −0.96; P = .34). The mean GCI score for the later-born siblings was 6 points lower (t = −1.6; P = .13).
Results From 2-Year vs 4-Year Assessments
As noted in TABLE 5, for children born to women with PKU or MHP, scores on the McCarthy Scales at age 4 years were significantly lower than scores on the Bayley Scales at age 2 years. For children in the non-HPA comparison group, the differences were not significant.
COMMENT
Delayed metabolic control in maternal PKU remains a serious problem. Treatment at any time during pregnancy appears to reduce the risks of cognitive impairment and developmental delay associated with untreated maternal PKU. Children are best protected from elevated maternal phenylalanine levels when the woman attains metabolic control prior to pregnancy. There is no evidence for a safe zone once pregnancy begins that marks a period in which the fetus is fully protected.
While there is no doubt that maternal phenylalanine levels higher than 10 mg/dL (605 µmol/L) during pregnancy affect the fetus, levels lower than 10 mg/dL (605 µmol/L) are not associated with significant declines in GCI scores. However, the mean GCI scores of children born to mothers with untreated MHP were somewhat lower than that of children born to mothers in the non-HPA comparison group. While this might suggest some effect from MHP, the women in the non-HPA group included physicians and other health care professionals working at the medical centers. EFFECT OF MATERNAL PHENYLKETONURIA ON OFFSPRING Their higher IQ and socioeconomic position might account for the somewhat higher scores among their offspring. When maternal metabolic control is not attained until after pregnancy begins, neuropsychological functions are differentially impaired. The developmental profile of maternal PKU offspring shows a distinct trend toward lower scores on tests of language, memory, and quantitative abilities, while motor skills and behavior are relatively less affected. Whether this reflects a fundamental processing deficit or an underlying language deficit may be clearer in subsequent testing of the children.
The scores obtained when the children were 4 years old were lower than the scores on the infant development test. This is not an artifact of the tests, since the children in the non-HPA comparison group did not display a significant decline in scores. The decline in scores for maternal PKU children may presage an inability to meet increasing cognitive and language demands in the future.
This cohort of women with PKU experienced significant difficulties planning their pregnancies, attending scheduled medical appointments, complying with dietary restrictions, and monitoring their metabolic status. Adhering to the diet did not become easier with successive pregnancies. Pregnancies of later-born offspring were not within metabolic control sooner than earlier pregnancies and outcomes were not better. The women were often less able to maintain metabolic control, apparently not because of biological or genetic factors, but because of a lack of resources, time, motivation, support, and organization. This finding underscores the relevance of psychosocial factors in maternal PKU.
Methodologically, the study presented challenges for long-term follow-up and data interpretation. Tracking, treatment compliance, adherence to the study protocol, and follow-up rates varied between centers. The mothers of children for whom the preschool evaluation was missing were younger and had a higher average plasma phenylalanine level during pregnancy. This suggests that an even greater proportion of children might have been in the latest treated groups. Despite the possible impact of maternal IQ on offspring outcome, this variable could not be completely controlled for in the analyses since it was so highly correlated with metabolic control during pregnancy and with other maternal variables. Nonetheless, the results provide compelling evidence for the importance of strict treatment for maternal PKU.
One of the more interesting aspects of maternal PKU is its dissimilarity in outcome to PKU and its similarity in outcome to other prenatal conditions. For example, unlike maternal PKU offspring, children with PKU, whose exposure to elevated phenylalanine occurs postnatally, have deficits in the areas of visuomotor skills and fine motor speed.
26 Untreated children with PKU are profoundly affected. They display autistic features or self-abusive behaviors. Children from late-treated or untreated maternal PKU pregnancies experience mental retardation, but not to a profound degree.
This observation suggests that the timing of exposure may determine the specific neuropsychological outcome. The literature on other maternal conditions also suggests that there may be effects in particular areas of functioning related primarily to timing and extent of exposure. For example, children born to women with high alcohol consumption are almost indistinguishable from children born to women with PKU. 4, 27 In fetal alcohol syndrome, studies have documented deficits in language, attention, memory, and information processing. 28 As in maternal PKU, a clear dose-response relationship has been identified. 29 Interventions directed at reducing risks at each step in the maternal PKU cycle may prove to be most effective. In terms of outcome, every week counts. Previous studies documented the importance of social support in preventing unplanned (and hence late-treated) pregnancies in women with PKU. 30 Camps, retreats, social support networks, newsletters, and other activities to enhance social support should be offered. 31, 32 The women may need hospitalization. 33 Compliance can sometimes be improved through changes in formula or through the use of capsules containing the formula. 34 In one home visitation program, mothers of children with PKU (called resource mothers) provided practical assistance and social support to pregnant women with PKU. A pilot study demonstrated that maternal metabolic control was achieved 4 weeks sooner and offspring outcome was significantly better in women who received the services of a resource mother. 35 After the infant's birth, the possibility that the home environment could moderate the adverse effects of maternal PKU should not be ignored. To date, extraordinary efforts are sometimes made to treat the woman during pregnancy, but then little assistance is offered following delivery. In this study, the postnatal environment was one of the stronger predictors of the GCI score. This finding coincides with the earlier result that maternal PKU children from families with low HOME scores performed less well at 1 year than children from families with adequate home stimulation, despite their initial neonatal neurological rating. 13 More research is needed to determine what interventions are effective in reducing risks for adverse outcomes before, during, and after pregnancy. 
